Medinol products

Medinol’s patented Flexx² technology is a game-changer in coronary deliverability, especially in tough anatomies. Flexx² is based on a tapered spring tip designed to eliminate tip flare out and buckling while enabling simultaneous flexibility and pushability. The entire coronary product line of Medinol builds on Flexx² catheters, including the EluNIR drug eluting stent system and the NC Gallant PTCA Catheter.

WiZeCell, our proprietary stent design is paradigm shift in cardiovascular stenting. The design’s sixth generation, the EluNIR drug eluting stent, relieves physicians from compromising between vessel conformability, scaffolding integrity, uniform drug distribution and radial support by offering an integrated design maximizing all benefits simultaneously.

From crimping through delivery through calcified lesions, expansion and drug elution, drug-eluting stents endure substantial mechanical and chemical stress. Inherently brittle, traditional polymer coatings of drug eluting stents have been shown to develop surface imperfections and deformations, which under stress can crack and even peel away from the stent • Such cracking and peeling can lead to uneven drug release that may result in under- and over-dosing of the vessel wall. Moreover, they were associated with inflammation and thrombogenicity